|
(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Inherited mitochondrial respiratory chain diseases |
| USA Market Approval | USA |
| USA Designation Date | 2014-11-17 00:00:00 |
| Sponsor | Khondrion BV;Philips van Leydenlaan 15, 6525 Ex Nijmegen; |
